• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气流阻塞分类方法与死亡率。

Airflow Obstruction Categorization Methods and Mortality.

机构信息

1 Intermountain Medical Center, Murray, Utah; and.

2 University of Utah, Salt Lake City, Utah.

出版信息

Ann Am Thorac Soc. 2018 Aug;15(8):920-925. doi: 10.1513/AnnalsATS.201802-104OC.

DOI:10.1513/AnnalsATS.201802-104OC
PMID:29979623
Abstract

RATIONALE

Current guidelines recommend using forced expiratory volume in 1 second (FEV) % predicted to categorize the severity of airflow obstruction. There are limitations to using FEV % predicted for this purpose, including bias associated with demographic factors and the inability to correct for "lung size." Other methods for grading the severity of airflow obstruction have been proposed to address these limitations.

OBJECTIVES

Our objectives were to categorize airflow obstruction severity using these methods and then determine which method results in a categorization most closely associated with mortality.

METHODS

Study subjects were patients aged 40-80 years tested in our pulmonary function test laboratories in the period 2002 to 2013 with airflow obstruction based on an FEV/forced vital capacity (FVC) less than the lower limit of normal. Categorization of airflow obstruction severity was determined using four methods: FEV % predicted; FEV % predicted adjusted by FVC % predicted; FEV/FVC confidence interval approach; and FEV z-scores. Receiver operating characteristic curve analysis was used to determine which categorization method best predicts 5-year survival.

RESULTS

We identified 2,000 patients with airflow obstruction. Important differences in the categorization of airflow obstruction severity were observed using the different methods. More patients were categorized as having severe obstruction using FEV % predicted and FEV z-scores compared with FEV % predicted adjusted by FVC % predicted and FEV/FVC confidence interval approach. FEV % predicted was the best predictor of 5-year survival among the four methods studied.

CONCLUSIONS

In our study, categorizing airflow obstruction severity using FEV % predicted best predicted 5-year survival. This validates the current guideline recommendation that FEV % predicted be used to categorize the severity of airflow obstruction.

摘要

原理

目前的指南建议使用 1 秒用力呼气量(FEV)占预计值的百分比来对气流阻塞的严重程度进行分类。但在实际应用中,使用 FEV 占预计值的百分比存在局限性,包括与人口统计学因素相关的偏差,以及无法纠正“肺容量”。为了解决这些局限性,已经提出了其他分级气流阻塞严重程度的方法。

目的

我们的目的是使用这些方法对气流阻塞严重程度进行分类,然后确定哪种方法与死亡率的相关性最高。

方法

研究对象为 2002 年至 2013 年间在我们的肺功能检测实验室接受检测的年龄在 40-80 岁之间的患者,这些患者存在基于 FEV/用力肺活量(FVC)低于正常值下限的气流阻塞。使用四种方法对气流阻塞严重程度进行分类:FEV 占预计值的百分比;FEV 占预计值与 FVC 占预计值之比校正后的 FEV 占预计值百分比;FEV/FVC 置信区间法;以及 FEV z 评分。使用受试者工作特征曲线分析确定哪种分类方法最能预测 5 年生存率。

结果

我们确定了 2000 例气流阻塞患者。使用不同方法观察到气流阻塞严重程度的分类存在重要差异。与 FEV 占预计值与 FVC 占预计值之比校正后的 FEV 占预计值百分比和 FEV/FVC 置信区间法相比,使用 FEV 占预计值和 FEV z 评分的患者中更多的患者被归类为严重阻塞。在我们的研究中,四种方法中,FEV 占预计值是预测 5 年生存率的最佳指标。

结论

在我们的研究中,使用 FEV 占预计值对气流阻塞严重程度进行分类最能预测 5 年生存率。这验证了目前的指南建议,即使用 FEV 占预计值对气流阻塞的严重程度进行分类。

相似文献

1
Airflow Obstruction Categorization Methods and Mortality.气流阻塞分类方法与死亡率。
Ann Am Thorac Soc. 2018 Aug;15(8):920-925. doi: 10.1513/AnnalsATS.201802-104OC.
2
A Comparison of Global Lung Initiative 2012 with Third National Health and Nutrition Examination Survey Spirometry Reference Values. Implications in Defining Obstruction.全球肺倡议 2012 与第三次国家健康和营养检查调查肺量测定参考值的比较。在定义阻塞中的意义。
Ann Am Thorac Soc. 2019 Feb;16(2):225-230. doi: 10.1513/AnnalsATS.201805-317OC.
3
Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.在韩国人群中,使用FEV1/FEV6作为FEV1/FVC的替代指标来检测气道阻塞的截断值。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 19;11:1957-63. doi: 10.2147/COPD.S113568. eCollection 2016.
4
Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.在澳大利亚和新西兰的认证肺功能实验室中,对于气流阻塞的肺功能解读实践存在很大差异。
Intern Med J. 2019 Jan;49(1):41-47. doi: 10.1111/imj.14047.
5
Relationship between airflow obstruction and coronary atherosclerosis in asymptomatic individuals: evaluation by coronary CT angiography.无症状个体中气流阻塞与冠状动脉粥样硬化的关系:冠状动脉CT血管造影评估
Int J Cardiovasc Imaging. 2018 Apr;34(4):641-648. doi: 10.1007/s10554-017-1259-z. Epub 2017 Nov 14.
6
Airflow obstruction, cognitive function and mortality in a US national cohort: NHANES-III.美国全国队列中的气流阻塞、认知功能与死亡率:第三次全国健康和营养检查调查(NHANES-III)
Clin Respir J. 2018 Mar;12(3):1141-1149. doi: 10.1111/crj.12643. Epub 2017 Jun 1.
7
The Impact of Using Non-Birth Sex on the Interpretation of Spirometry Data in Subjects With Air-Flow Obstruction.使用非出生时性别对气流受限受试者肺量计数据解读的影响
Respir Care. 2018 Feb;63(2):215-218. doi: 10.4187/respcare.05586. Epub 2017 Nov 28.
8
Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV in Severe Airflow Obstruction.在严重气流受限患者中,用力肺活量(FVC)的支气管扩张剂反应比第一秒用力呼气容积(FEV)更大且更具相关性。
Chest. 2017 May;151(5):1088-1098. doi: 10.1016/j.chest.2016.12.017. Epub 2016 Dec 28.
9
Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment.预测肺活量测定技术不充分以及将FEV1/FEV3作为轻度认知障碍患者FEV1/FVC的替代指标。
Clin Respir J. 2008 Oct;2(4):208-13. doi: 10.1111/j.1752-699X.2008.00063.x.
10
Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV/FVC Ratio?用力肺活量/肺总量比值正常者,缓慢肺活量临床检测是否有助于发现气流受限?
Chest. 2019 Sep;156(3):497-506. doi: 10.1016/j.chest.2019.02.001. Epub 2019 Feb 12.

引用本文的文献

1
Nomogram to predict progression from preserved ratio impaired spirometry to chronic obstructive pulmonary disease.预测从肺功能比值保留但肺量计测定受损进展为慢性阻塞性肺疾病的列线图。
Sci Rep. 2025 Mar 26;15(1):10447. doi: 10.1038/s41598-025-93359-w.
2
Genetic spectrum and genotype-phenotype correlations in DNAH5-mutated primary ciliary dyskinesia: a systematic review.DNAH5 突变所致原发性纤毛运动障碍的遗传谱及基因型-表型相关性:一项系统综述
Orphanet J Rare Dis. 2025 Mar 3;20(1):97. doi: 10.1186/s13023-025-03596-5.
3
Risk Factors of FEV₁/FVC Decline in COPD Patients.
慢性阻塞性肺疾病患者第一秒用力呼气容积/用力肺活量下降的危险因素。
J Korean Med Sci. 2025 Feb 17;40(6):e32. doi: 10.3346/jkms.2025.40.e32.
4
Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations.肺量测定解读策略的变化:对 COPD 分类和预测加重的影响。
Chest. 2024 Aug;166(2):294-303. doi: 10.1016/j.chest.2024.03.034. Epub 2024 Mar 26.
5
Comparison of Disease Severity Classifications of Chronic Obstructive Pulmonary Disease: GOLD vs. STAR in Clinical Practice.慢性阻塞性肺疾病疾病严重程度分类的比较:临床实践中全球慢性阻塞性肺疾病倡议(GOLD)与慢性阻塞性肺疾病评估测试(STAR)的对比
Diagnostics (Basel). 2024 Mar 19;14(6):646. doi: 10.3390/diagnostics14060646.
6
A STAR Is Born: A New Approach to Assessing Chronic Obstructive Pulmonary Disease Severity.一颗新星诞生:评估慢性阻塞性肺疾病严重程度的新方法。
Am J Respir Crit Care Med. 2023 Sep 15;208(6):647-648. doi: 10.1164/rccm.202306-1106ED.
7
FEV/FVC Severity Stages for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的 FEV/FVC 严重程度分期。
Am J Respir Crit Care Med. 2023 Sep 15;208(6):676-684. doi: 10.1164/rccm.202303-0450OC.
8
Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study.肺功能受损与东欧人群死亡率:一项多中心队列研究结果
Respir Res. 2022 May 31;23(1):140. doi: 10.1186/s12931-022-02057-y.
9
Update in Chronic Obstructive Pulmonary Disease 2018.2018年慢性阻塞性肺疾病的最新进展
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1462-1470. doi: 10.1164/rccm.201902-0374UP.